top of page
GBX_EVENTS_2024_womeninscience_#GBX_Staff_#CGTI_#BILS_DDIF_#MEVO
GBX Events Icon

17th Annual Bio Innovation Leaders Summit 2025

12th & 13th February 2025
Raffles Singapore

Jens H. Vogel

President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

Jens H. Vogel, Previous SVP & Global Biotech at Bayer is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Uwe Gottschalk

Operating Partner at Keensight Capital - Former CSO of Lonza

Uwe Gottschalk, Operating Partner at Keensight Capital - Previous CSO of Lonza is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Jesse McCool

CSO of Bionova Scientific - Former Co-Founder & CEO of Wheeler Bio

Jesse McCool, Co-Founder & CEO of Wheeler Bio is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Angela Vollstedt

Global R&D Director Cell & Gene Therapies Portfolio at Novartis

Angela Vollstedt, Global Director, Cell & Gene Therapies Portfolio Management at Novartis is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Behzad Mahdavi, CEO & Board Member at InnoGi Technologies #BILS is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Behzad Mahdavi

CEO & Board member at InnoGI Technologies & Executive Chairman at Open Cell Technologies

For the patients, we must do better.

BILS 2026. The 17th Annual Bioinnovation Leaders Summit 2026

 

This exclusive gathering will host up to 200 qualified leaders, including business executives, VPs, and C-suite executives, in person only. It will provide a unique opportunity to engage in high-level discussions on how biomanufacturing is not only driving innovation and business growth but also enhancing patient outcomes and shaping a more sustainable healthcare future.

Impromptu testimonials

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Learn more

Confirmed Speakers

Learn more

Register Interest

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Learn more

Programme

CURRENT ​SPEAKERS 

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

AGENDA SCHEDULE

Key Topics

  • Expansion of Continuous Biomanufacturing

  • Emphasis on Sustainable Biomanufacturing Practices

  • Growth of Advanced Therapy Medicinal Products (ATMPs)

  • Advancement of Digital Biomanufacturing

  • Integration of Artificial Intelligence and Machine Learning

  • Bioprocessing Equipment Suppliers

  • CDMOs 

  • Analytical & Testing Services 

  • Facility Design & Engineering

  • Automation & Software Vendors

  • Sustainability and Green Manufacturing Vendors 

  • Biomanufacturing is the engine that brings breakthrough medicines to life and into the hands of patients who need them most. It plays a crucial role in making advanced treatments—like cancer immunotherapies, vaccines, and gene therapies—safe, reliable, and widely available.

GBX-Icon_Negative-Orange.png
Joshi Venugopal, GM & Head of Europe at Novartis Gene Therapies & Rare Diseases #BILS

Joshi Venugopal

GM & Head of Europe

Novartis Gene Therapies & Rare Diseases

GBX-Icon_Negative-Orange.png
Dorothee Ambrosius.png

Dorothee Ambrosius

Former Head of CMC Strategy Biologicals

Boehringer Ingelheim

GBX-Icon_Negative-Orange.png
Warner Biddle, Previous Global Head of Commercial at Kite, a Gilead Company #BILS_edited.p

Warner Biddle

Former Global Head of Commercial

Kite, a Gilead Company

GBX-Icon_Negative-Orange.png
Gwendolyn Binder, President, Science & Technology at Cabaletta Bio #BILS_edited.png

Gwendolyn Binder

President of Science & Technology

Cabaletta Bio

GBX-Icon_Negative-Orange.png
Pierre Caloz, COO of uniQure #BILS

Pierre Caloz

COO

uniQure

GBX-Icon_Negative-Orange.png
Paolo Martini, Previous CSO of Moderna #BILS_edited.png

Paolo Martini

Former CSO

Moderna

Warner Biddle, former SVP at Kite Pharma speaking at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

IN PERSON ONLY

Benchmark with up to only 200 leaders across Biopharma

SUMMIT
INSIGHTS

Our Mission

Our purpose is to create a gathering that empowers and inspires critical decision-making; sparking new opportunities to amplify their impact within the biologics and cell and gene therapy value chain.

We encourage collaboration and innovation, which is why this summit ensures that each participant contributes significantly to advancing the field. It serves as a platform for sharing insights, fostering partnerships and driving forward the next wave of breakthroughs in biologics.

For the patients, we must do better. 

Click to view testimonials

Investors and large biopharma companies need to satisfy environmental compliance. We will keynote the progression toward more sustainable bioprocesses, manufacturing and supply methods, amalgamating toward building a sustainable and digitised ecosystem - an emerging frontier of digitisation and industry 4.0.

Closing session by Merck.

Attendee Profile

C-Suite - Directors - Executives

Bioprocess - Manufacturing - IT-Data Integration - Commercial and Business Development - Scientists - Supply Chain - Production - PAT

 

Focus Area 

CGT

Antibody Drugs 

Vaccine

Small molecule, conjugates and peptides 

Technology or Service Companies

CRO

CDMO

Biologic workflow solutions

Advance Bioprocessing 

End to end workflow solutions

Digitising - AI - Data

Automation - Robotics

Filtration - Single use - Bioreactors

Event highlights

Pre Event Innovation Tour - Private Innovation Tour - CXO

Please click to Tour 2024

Evening of day one -Private Networking Dinner 

Journey of a CXO

Exclusive closed-door talks from some of the most prominent leaders in the industry who will be talking about their journey, lessons learnt and vision for the future.

Attendance Guide

30% Asian Biopharma

25% International Biopharma

20% CMOs - CDMOS's

15% Academic & Research Institutes

10% Technology & Service Providers

Curated Meetings

Packages have sold out

Guaranteed pre-qualified strategy meetings 

Prior contact

Mutual benefit

Conducted by our specialists

Geography

25% Korea & Japan

20% Singapore

20% Indonesia, Thailand, Philippines, Malaysia, India & Australia

15% China, Hong Kong & Taiwan

15% USA

5% UAE

PREVIOUS SPEAKERS

Jens H. Vogel, SVP & Global Head of Biotech at Bayer speaking at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

For the patients, we must do better

ADVISORY

“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change” Martin Luther King

GBXEVENTS2024_Staff_edited.jpg

Subscribe to Our Mailing List

bottom of page